Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Chubb
AstraZeneca
Deloitte
UBS
Cipla
McKinsey
Healthtrust
Accenture

Generated: June 24, 2018

DrugPatentWatch Database Preview

UNISOM Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Unisom patents expire, and when can generic versions of Unisom launch?

Unisom is a drug marketed by Pfizer and Chattem and is included in two NDAs.

The generic ingredient in UNISOM is doxylamine succinate. There are fourteen drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the doxylamine succinate profile page.
Drug patent expirations by year for UNISOM
Medical Subject Heading (MeSH) Categories for UNISOM
Synonyms for UNISOM
(Dimethylamino)ethoxy-methyl-benzyl-pyridine succinate
[[[(2-Dimethylamino)ethoxy]phenyl]methyl]-2-picoline succinate
2-(alpha-(2-Dimethylaminoethoxy)-alpha-methylbenzyl)pyridine succinate
2-(alpha(2-(Dimethylamino)ethoxy)-alpha-methylbenzyl)pyridine succinate (1:1)
2-[[.alpha.-(2-Dimethylamino)ethoxy]-.alpha.-methylbenzyl]pyridine succinate
2-[a-[2-(Dimethylamino)ethoxy]-a-methylbenzyl]pyridine succinate
2-Dimethylaminoethoxyphenylmethyl-2-picoline succinate
2-Dimethylaminoethoxyphenylmethyl-2-picoline succinate (1:1)
562-10-7
A-H Injection
AB0017830
AC-4487
AC1L1WW1
AC1Q5VR4
ACM1216840946
AI3-23993
AKOS025310916
alpha-(2-Dimethylaminoethoxy)-alpha-methyl-alpha-phenyl-2-picoline acid succinate
Alsadorm
AN-11902
API0002494
AS-13661
BC678008
BG0679
Butanedioic acid, compd. with N,N-dimethyl-2-(1-phenyl-1-(2-pyridinyl)ethoxy)ethanamine
Butanedioic acid, compd. with N,N-dimethyl-2-(1-phenyl-1-(2-pyridinyl)ethoxy)ethanamine (1:1)
Butanedioic acid, compd. with N,N-dimethyl-2-(1-phenyl-1-(2-pyridinyl)ethoxy)ethanamine (1:1) (9CI)
Butanedioic acid, compd. with N,N-dimethyl-2-[1-phenyl-1-(2-pyridinyl)ethoxy]ethanamine (1:1)
Butanedioic acid,N-dimethyl-2-[1-phenyl-1-(2-pyridinyl)ethoxy]ethanamine (1:1)
butanedioic acid,N,N-dimethyl-2-(1-phenyl-1-pyridin-2-ylethoxy)ethanamine
butanedioic acid; N,N-dimethyl-2-(1-phenyl-1-pyridin-2-ylethoxy)ethanamine
butanedioic acid;N,N-dimethyl-2-(1-phenyl-1-pyridin-2-ylethoxy)ethanamine
C17H22N2O.C4H6O4
C19414
C21H28N2O5
CAS-562-10-7
CCG-101033
CCG-38929
CCRIS 4811
CHEBI:82461
CHEMBL1200392
CPD000058436
CS-3232
D 3775
D-9200
D02327
Decapryn
Decapryn (TN)
Decapryn Succinate
Decapryn succinate (1:1)
Decarpyn succinate (1:1)
Dimethylaminoethoxy-methyl-benzyl-pyridine succinate
Doxy-sleep-aid
Doxylamine (succinate)
Doxylamine for system suitability, European Pharmacopoeia (EP) Reference Standard
Doxylamine hydrogen succinate
Doxylamine Hydrogen Succinate 1.0 mg/ml in Methanol (as free base)
Doxylamine hydrogen succinate, European Pharmacopoeia (EP) Reference Standard
Doxylamine succinate
Doxylamine succinate (1:1)
Doxylamine succinate (USP)
Doxylamine succinate [USP]
Doxylamine succinate liquid
Doxylamine succinate salt
Doxylamine Succinate, pharmaceutical secondary standard; traceable to USP, PhEur
Doxylamine succinate, United States Pharmacopeia (USP) Reference Standard
Doxylamine-d5 Succinate
doxylamine; succinic acid
DSSTox_CID_552
DSSTox_GSID_20552
DSSTox_RID_75656
DTXSID7020552
EINECS 209-228-7
EQUALINE SLEEP AID
Ethanamine, N,N-dimethyl-2-(1-phenyl-1-(2-pyridinyl)ethoxy)-, butanedioate (1:1)
EU-0100348
Evigoa D
F2173-1155
FT-0082833
FT-0625595
Gittalun
HE009961
HMS1568E15
HMS1920K04
HMS2051F14
HMS2091B09
HMS2095E15
HMS2231G05
HMS3261E17
HMS3370K04
HMS3393F14
HMS3652H19
HMS502K03
Hoggar N
HY-A0069
J10070
KB-295989
LP00348
LS-1380
Mereprine
MFCD00056168
MLS000028417
MLS000758288
MLS001076141
MLS001424137
MLS002222274
MolPort-003-666-172
N,N-dimethyl-2-(1-phenyl-1-(pyridin-2-yl)ethoxy)ethanamine succinate
n,n-dimethyl-2-(1-phenyl-1-pyridin-2-ylethoxy)ethanamine butanedioate
N,N-dimethyl-2-(1-phenyl-1-pyridin-2-ylethoxy)ethanamine succinate
N,N-Dimethyl-2-[1-phenyl-1-(2-pyridinyl)ethoxy]ethenamine succinate
N,N-dimethyl-2-[1-phenyl-1-(2-pyridyl)ethoxy]ethanamine; succinic acid
N,N-dimethyl-2-[1-phenyl-1-pyridin-2-ylethoxy]ethanamine succinate
NC00283
NCGC00016140-02
NCGC00016140-03
NCGC00016140-04
NCGC00017028-02
NCGC00021147-11
NCGC00089789-03
NCGC00093785-01
NCGC00093785-02
NCGC00093785-03
NCGC00256517-01
NCGC00259627-01
NCGC00261033-01
NSC 74772
NSC-74772
NSC-756752
NSC74772
NSC756752
Opera_ID_566
Pharmakon1600-01500267
Phenyl2-pyridylmethyl-(.beta.-N,N-dimethylamino)ethyl ether succinate
Phenyl2-pyridylmethyl-beta-N,N-dimethylaminoethyl ether succinate
Prestwick_887
Pyridine, 2-(alpha-(2-(dimethylamino)ethoxy)-alpha-methylbenzyl)-, succinate (1:1)
Pyridine, succinate (1:1)
Q835
s4240
Safetussin
SAM001247030
SCHEMBL160443
Sedaplus
SMR000058436
SPECTRUM1500267
Succinic acid, compd. with 2-(alpha-(2-(dimethylamino)ethoxy)-alpha-methylbenzyl)pyridine (1:1)
Succinic acid, compd. with 2-(alpha-(2-(dimethylamino)ethoxy)-alpha-methylbenzyl)pyridine (1:1) (8CI)
Succinic acid, compd. with 2-[.alpha.-[2-(dimethylamino)ethoxy]-.alpha.-methylbenzyl]pyridine (1:1)
Topcare sleep aid
Tox21_113515
Tox21_113515_1
Tox21_202078
Tox21_302861
Tox21_500348
WLN: T6NJ BX1&R&O2N1&1 &OV2VO

US Patents and Regulatory Information for UNISOM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer UNISOM doxylamine succinate CAPSULE;ORAL 019440-001 Feb 5, 1986 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Chattem UNISOM doxylamine succinate TABLET;ORAL 018066-001 Approved Prior to Jan 1, 1982 OTC Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Cipla
Federal Trade Commission
Deloitte
Daiichi Sankyo
Queensland Health
Chinese Patent Office
QuintilesIMS
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.